[Characteristics of kidney disorders in lymphogranulomatosis].

Destruction of human cells in tissue culture by lymphocytes from patients with systemic lupus erythematosus. Lancet (1966) 1.43

[Clinicomorphological characteristics of renal disorders in patients with genetic thrombophilia]. Ter Arkh (2009) 0.81

[Masks of subacute infectious endocarditis]. Ter Arkh (1999) 0.80

[Clinical diagnosis progress and continuing medical education]. Ter Arkh (2014) 0.80

[Immune complex hyperuricemic nephritis: aspects of its morphology and pathogenesis]. Ter Arkh (1986) 0.79

[Rheumatoid nephropathy]. Sov Med (1972) 0.78

[The role of smooth muscle alpha-actin in development of renal fibrosis in patients with chronic glomerulonephritis]. Ter Arkh (2006) 0.78

[Nephrotic syndrome in a patient with systemic mastocytosis]. Klin Med (Mosk) (1983) 0.78

[The morphological heterogeneity of mesangioproliferative glomerulonephritis]. Arkh Patol (1990) 0.77

[Extrahepatic manifestations of chronic hepatitis C]. Ter Arkh (1998) 0.77

[Urinary enzymes as a marker of the preclinical stage of diabetic nephropathy]. Ter Arkh (1989) 0.77

Protein-loading test, urinary albumin excretion and renal morphology in diagnosis of subclinical diabetic nephropathy. J Intern Med (1992) 0.77

Renal functional reserve in diabetic patients without clinical nephropathy: comparisons with renal morphology. Diabet Med (1991) 0.76

[The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II]. Ter Arkh (1989) 0.76

[Urinary enzymes in the assessment of the early stage of kidney involvement in psoriasis and diabetes mellitus]. Ter Arkh (1995) 0.76

[Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression]. Ter Arkh (2006) 0.76

[Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease]. Ter Arkh (2012) 0.76

[Clinico-morphological variants of mesangioproliferative glomerulonephritis]. Ter Arkh (1990) 0.76

[The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients]. Ter Arkh (2011) 0.76

[Functional and morphological characteristics of a hematuric form of chronic glomerulonephritis]. Klin Med (Mosk) (1990) 0.76

[The immunohistochemical heterogeneity of mesangioproliferative glomerulonephritis]. Arkh Patol (1990) 0.76

[Cobalt-induced cardiomyopathy in workers engaged in the manufacture of hard alloys]. Ter Arkh (1991) 0.76

[Clinico-morphological characteristics and prognosis of glomerulonephritis in chronic alcoholism]. Ter Arkh (1986) 0.76

[Primary glomerulopathies: incidence, dynamics and clinical manifestations of morphological variants]. Arkh Patol (2002) 0.76

[Vascular purpura in patients with chronic diffuse hepatic diseases]. Klin Med (Mosk) (2005) 0.76

[Diabetes mellitus--immunologic aspects]. Ter Arkh (1986) 0.75

[Senile pyelonephritis with the arterial hypertension syndrome: the use of trental]. Ter Arkh (1991) 0.75

[Immunological status in clinical medicine]. Ter Arkh (1982) 0.75

[Effect of heterogenic antilymphocyte serum on the development of nephrotoxic nephritis in rats]. Biull Eksp Biol Med (1971) 0.75

[Immunologic aspects of renal involvement in patients with type II diabetes mellitus]. Probl Endokrinol (Mosk) (1994) 0.75

[Senile pyelonephritis: the pathophysiology of the hypertension syndrome]. Ter Arkh (1993) 0.75

[Pneumocystic pneumonia with lethal outcome in male with Wegener's granulomatosis]. Ter Arkh (2000) 0.75

[Secondary amyloidosis in patient with Kaposi's sarcoma]. Ter Arkh (1999) 0.75

[Changes in leukocyte enzyme activity during experimental amyloidogenesis and in patients with amyloidosis]. Biull Eksp Biol Med (1976) 0.75

[Acute renal insufficiency in middle-aged and aged patients]. Ter Arkh (1987) 0.75

[Circulating immune complexes in rheumatic diseases]. Ter Arkh (1981) 0.75

[Certain indicators of cellular immunity in amyloidosis (experimental clinical study)]. Sov Med (1975) 0.75

[Cytochemical changes in peripheral blood neutrophils in collagen diseases and nephropathies]. Vestn Akad Med Nauk SSSR (1970) 0.75

[Results of clinical-dispensary treatment of nephrological patients with renal function disorders]. Ter Arkh (1977) 0.75

[Leukocyte migration inhibition as a method of detecting cellular hypersensitivity in autoimmune diseases]. Ter Arkh (1973) 0.75

[Amyloid transfer from a syngenous transplant of amyloid spleen in intact and amyloid mice]. Biull Eksp Biol Med (1978) 0.75

[Blast transformation reaction in systemic lupus erythematosus]. Vestn Akad Med Nauk SSSR (1970) 0.75

[Cellular aspects of immuno-inflammatory involvement of the kidneys]. Ter Arkh (1987) 0.75

[Gerontological and geriatric problems of nephrology]. Ter Arkh (1981) 0.75

[Renal lesions in elderly patients with diabetes mellitus]. Ter Arkh (1998) 0.75

[Pyelonephritis in old age]. Ter Arkh (1983) 0.75

[Endogenous opiate neuropeptides and the immune system]. Ter Arkh (1984) 0.75

[Achievements of nephrology in the 11th Five-Year Plan and its developmental prospects]. Ter Arkh (1986) 0.75

[The population aspects of renal arterial hypertension]. Ter Arkh (1997) 0.75

[Amyloid resorption in the transplantation of the spleen into intact and amyloid recipients]. Biull Eksp Biol Med (1974) 0.75

[Achievements and problems in nephrology]. Ter Arkh (1984) 0.75

[Kidneys involvement in multiple myeloma. Therapeutic issues]. Klin Med (Mosk) (1997) 0.75

[The effect of rat lymphocytes treated with Freund's adjuvant on tissue culture fibroblasts]. Biull Eksp Biol Med (1967) 0.75

[Treatment of anaphylactic shock and bronchial asthma with spirazidin in experimental and clinical conditions]. Vrach Delo (1969) 0.75

[Image contrasting nephropathy in patients with NIDDM: risk factors]. Klin Med (Mosk) (1998) 0.75

[The cellular immunity indices in diabetic nephropathy]. Ter Arkh (1991) 0.75

[Heart damage in white rats following their exposure to Freund's stimulant]. Arkh Patol (1968) 0.75

[Current approaches to the problem of macrohematuria]. Ter Arkh (1982) 0.75

[Structure of the pathology of the senile kidney and its diagnostic difficulties]. Ter Arkh (1986) 0.75

[Immunosuppressive properties of a new cytostatic agent of beta-chloroethylene series, spirazidine]. Sov Med (1969) 0.75

[Acute-onset nephritis in middle-aged and elderly patients]. Ter Arkh (1985) 0.75

[Nephritis in middle-aged and elderly subjects]. Ter Arkh (1995) 0.75

[Blast transformation of lymphocytes in chronic kidney diseases]. Ter Arkh (1975) 0.75

[Effect of hemosorption on the level of circulating immune complexes in diseases of the internal organs (I)]. Ter Arkh (1982) 0.75

[A case of an attempt on the life of an individual by the use of a gamma irradiator]. Ter Arkh (1994) 0.75

[Diabetic and gouty nephropathies (certain aspects)]. Ter Arkh (1995) 0.75

[Current treatment of lymphogranulomatosis]. Vopr Onkol (1970) 0.75

[Blood tyrosine and the corticosteroid treatment of systemic lupus erythematosus]. Ter Arkh (1977) 0.75

[Tubulointerstitial nephritis and arterial hypertension--their clinical and population significance]. Ter Arkh (1997) 0.75

[Chromosomal instability related to disordered replication and repair processes of DNA synthesis in the cells of patients with gouty nephropathy]. Genetika (1988) 0.75

[Interrelation of autoimmune and immune complex pathology: the current status of the problem]. Ter Arkh (1984) 0.75

[Programmed hemodialysis in middle and old age]. Ter Arkh (1994) 0.75

[Development of nephrology in the USSR in the last 5-year period (Problem-solving Commission on Nephrology]. Ter Arkh (1981) 0.75

[The epidemiological indices of multiple myeloma and concomitant nephropathies]. Ter Arkh (1997) 0.75

[Circulating immune complexes (PEG tests) in systemic lupus erythematosus]. Ter Arkh (1982) 0.75

[Clinico-immunological study of rheumatoid arthritis in middle-aged and elderly patients]. Ter Arkh (1987) 0.75

[Amyloidosis: several aspects of its clinical course and pathogenesis]. Ter Arkh (1977) 0.75

[Morphogenetic bases of an experimental therapy for amyloidosis]. Arkh Patol (1974) 0.75

[Characteristics of the immune complex process in patients with systemic lupus erythematosus with predominant kidney involvement]. Ter Arkh (1986) 0.75

[Urinalysis in the history of medical diagnosis]. Ter Arkh (1998) 0.75

[Effect of levamisole on various indicators of cellular immunity in amyloidosis]. Ter Arkh (1978) 0.75

[Several indices of the state of cellular immunity in amyloidosis (experimental-clinical study)]. Sov Med (1975) 0.75

[Activity of short-lived suppressor lymphocytes in rheumatoid arthritis]. Ter Arkh (1985) 0.75

[Immunology of systemic lupus erythematosus (literature review)]. Ter Arkh (1970) 0.75

[Achievements of nephrology in USSR during the 9th five-year plan and perspectives of its development]. Ter Arkh (1976) 0.75

[Clinico-pathogenetic aspects of Felty's syndrome]. Ter Arkh (1983) 0.75

[Current allergic theory and immunology of bronchial asthma]. Ter Arkh (1966) 0.75

[Clinico-immunological evaluation by a spectrophotometric method of determining cryoglobulins in rheumatic diseases]. Revmatologiia (Mosk) (1988) 0.75

[Tyrosine metabolism in systemic lupus erythematosus and therapeutic use of corticosteroid hormones. Preliminary report]. Ter Arkh (1974) 0.75

[Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation]. Ter Arkh (1983) 0.75

[Nephrotic syndrome in systemic lupus erythematosus]. Ter Arkh (1966) 0.75

[The age-related aspects of gouty nephropathy]. Ter Arkh (1991) 0.75

[Laboratory support for the immunological and allergological services in a general medical center]. Klin Lab Diagn (1996) 0.75

[Chemotherapy of lung cancer]. Vopr Onkol (1965) 0.75

[The immune system and nephropathies]. Ter Arkh (1984) 0.75

[The inhibiting effect of L-cysteine on the process of amyloid fibril formation in vitro and in vivo]. Biull Eksp Biol Med (1970) 0.75

[Modern approaches to the problem of pyelonephritis]. Ter Arkh (1982) 0.75

[Factors associated with progression of kidney diseases and principal possibilities of affecting them]. Ter Arkh (1998) 0.75

[Disordered repair processes in patients with gouty nephropathy]. Ter Arkh (1986) 0.75

[Fibronectin in health and pathology]. Ter Arkh (1991) 0.75